Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Ataxia - paediatric

Gene: EPM2A

Green List (high evidence)

EPM2A (EPM2A, laforin glucan phosphatase)
EnsemblGeneIds (GRCh38): ENSG00000112425
EnsemblGeneIds (GRCh37): ENSG00000112425
OMIM: 607566, Gene2Phenotype
EPM2A is in 13 panels

1 review

Bryony Thompson (Royal Melbourne Hospital)

Green List (high evidence)

Well-established gene-disease association. The condition is typically adolescent-onset progressive myoclonus epilepsy with progressive neurological degeneration, including cognitive and/or behavioural deterioration, dysarthria, ataxia, and, at later stages, spasticity and dementia. Periodic acid Schiff-positive intracellular polyglucason inclusion bodies (Lafora bodies) on skin biopsy are also a suggestive finding of the disease.
ClinGen Epilepsy GCEP have classified the gene-disease validity as DEFINITIVE. Classification - 05/23/2020.
Created: 1 Apr 2022, 5:52 a.m. | Last Modified: 1 Apr 2022, 5:52 a.m.
Panel Version: 0.12422

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Lafora disease MONDO:0009697

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Royal Melbourne Hospital
  • Expert Review Green
Phenotypes
  • Progressive myoclonic epilepsy 2A, Lafora, 254780
  • Epilepsy, progressive myoclonic 2A (Lafora) 254780
OMIM
607566
Clinvar variants
Variants in EPM2A
Penetrance
None
Panels with this gene

History Filter Activity

19 Dec 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: EPM2A was added gene: EPM2A was added to Ataxia - paediatric_RMH. Sources: Expert Review Green,Royal Melbourne Hospital Mode of inheritance for gene: EPM2A was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: EPM2A were set to Progressive myoclonic epilepsy 2A, Lafora, 254780; Epilepsy, progressive myoclonic 2A (Lafora) 254780